Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2015 /
Comment: Metastatic triple-negative breast cancer responds to immunotherapy

18th - 22nd Apr 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 01.05.15
Views: 2346
Rating:

Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA

Dr Louis Weiner comments on Prof Leisha Emen's research for ecancertv at AACR 2015. He covers how patients with triple-negative breast cancer have a worse prognosis than patients with other breast cancer subtypes, and in the United States, there is currently no targeted treatment available.

He also discusses high hopes for future treatments with an investigational targeted immunotherapy under development directed at metastatic triple-negative breast cancer.

Read the news story or watch the press conference or  interview with Prof Emens for more.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation